Apollo Endosurgery, Inc.
(NASDAQ : APEN)

( )
APEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -2.99%576.911.0%$828.43m
DHRDanaher Corp. -3.85%303.830.7%$644.33m
ABTAbbott Laboratories -1.47%118.810.8%$541.71m
ISRGIntuitive Surgical, Inc. -2.10%992.492.3%$519.72m
MDTMedtronic Plc -2.21%125.900.6%$451.27m
BDXBecton, Dickinson & Co. -0.62%249.881.0%$351.66m
ALGNAlign Technology, Inc. -3.38%677.326.3%$324.46m
BAXBaxter International, Inc. 0.22%80.751.8%$315.74m
HRCHill-Rom Holdings, Inc. 0.19%149.572.2%$312.56m
IDXXIDEXX Laboratories, Inc. -3.57%626.853.8%$298.98m
DXCMDexCom, Inc. -2.21%536.947.8%$289.83m
SYKStryker Corp. -2.12%267.691.3%$269.52m
BSXBoston Scientific Corp. -1.69%43.711.0%$256.32m
ZBHZimmer Biomet Holdings, Inc. -0.47%150.831.7%$244.56m
AAgilent Technologies, Inc. -3.86%159.961.6%$224.76m

Company Profile

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System, and Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders; esophageal stent fixation and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.